Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update
Globe Newswire•19/08/2026•16:30 ET
0
Whiz Insights
REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced financial results for the first half of 2026 and provided a business update.
A supplemental long‑form earnings release and management presentation providing additional details and business update is available on our website: https://alvotech.com/financials.(1)
Get started
Create a free account to read the full story.